These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7368759)

  • 21. [Cephazolin and cephapirin circulation in the blood of rabbits].
    Klimova VS
    Antibiotiki; 1978 Sep; 23(9):814-6. PubMed ID: 697339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic investigations of cefazedone in gynaecology and obstetrics.
    von Kobyletzki D; Sas M; Dingeldein E; Wahlig H; Wiemann H
    Arzneimittelforschung; 1979; 29(11):1763-8. PubMed ID: 543888
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. III. Investigations of the mechanism of renal elimination.
    Ungethüm W; Pabst J; Dingeldein E; Leopold G
    Arzneimittelforschung; 1979; 29(2a):443-8. PubMed ID: 582723
    [No Abstract]   [Full Text] [Related]  

  • 24. [Absorption and excretion of cephapirin (author's transl)].
    Morikawa A; Maruta H; Mizuno D
    Jpn J Antibiot; 1974 Apr; 27(2):182-4. PubMed ID: 4546584
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics of cefazolin patients with normal and impaired renal function.
    Bergan T; Brodwall EK; Orjavik O
    J Antimicrob Chemother; 1977 Sep; 3(5):435-43. PubMed ID: 903324
    [No Abstract]   [Full Text] [Related]  

  • 26. Tissue penetration and binding of antibiotics.
    Selwyn S
    J Antimicrob Chemother; 1977 Jan; 3(1):105-6. PubMed ID: 845101
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood, urine and tissue concentrations of the cephalosporin antibiotics in normal subjects.
    Griffith RS; Black HR
    Postgrad Med J; 1971 Feb; 47():Suppl:32-40. PubMed ID: 5556188
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of L-phenylalanine supplementation and a high-protein diet on pharmacokinetics of cefdinir in healthy volunteers: an exploratory study.
    Fujita T; Nakamura K; Yamazaki A; Ozaki M; Sahashi K; Shichijo K; Nomura K; Maeda M; Nakamura T; Fujita T; Yokota S; Kuroyama S; Kumagai Y; Majima M; Ohtani Y
    J Clin Pharm Ther; 2007 Jun; 32(3):277-85. PubMed ID: 17489880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous determination of cefazolin in rat blood and brain by microdialysis and microbore liquid chromatography.
    Tsai TH; Chen YF
    Biomed Chromatogr; 2000 Jun; 14(4):274-8. PubMed ID: 10861740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of plasma albumin on theophylline concentration in lung tissue].
    Hosoya J; Sato S; Nakagawa Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct; 33(10):1038-43. PubMed ID: 8544373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfer of cefazolin into human milk.
    Yoshioka H; Cho K; Takimoto M; Maruyama S; Shimizu T
    J Pediatr; 1979 Jan; 94(1):151-2. PubMed ID: 758399
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics of cefovecin in cats.
    Stegemann MR; Sherington J; Coati N; Brown SA; Blanchflower S
    J Vet Pharmacol Ther; 2006 Dec; 29(6):513-24. PubMed ID: 17083455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long half-life for cefazolin in anuria.
    Moore TD; Seth SK
    Ann Intern Med; 1978 Feb; 88(2):269-70. PubMed ID: 626466
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of cefepime administered by i.v. and i.m. routes to ewes.
    Ismail M
    J Vet Pharmacol Ther; 2005 Dec; 28(6):499-503. PubMed ID: 16343281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefazolin plasma concentrations and urinary excretion in patients with renal impairment.
    Czerwinski AW; Pederson JA; Barry JP
    J Clin Pharmacol; 1974 Oct; 14(10):560-6. PubMed ID: 4430733
    [No Abstract]   [Full Text] [Related]  

  • 36. [Absorption and excretion of cefatrizine (S-640 P) in mouse and rat (author's transl)].
    Matsuzaki M; Nakamura K; Hirata Y; Matsumoto H; Ochiai K
    Jpn J Antibiot; 1976 Jan; 29(1):69-76. PubMed ID: 1263341
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics and penetration characteristics of cefazolin into human spinal fluid.
    Bassaris HP; Quintiliani R; Maderazo EG; Tilton RC; Nightingale CH
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):110-20. PubMed ID: 812655
    [No Abstract]   [Full Text] [Related]  

  • 38. [Study on cefazolin concentration in bone marrow (author's transl)].
    Kawashima M
    Jpn J Antibiot; 1980 Mar; 33(3):249-52. PubMed ID: 7401305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous infusion versus intermittent administration of cefepime in patients with Gram-negative bacilli bacteraemia.
    Jaruratanasirikul S; Sriwiriyajan S; Ingviya N
    J Pharm Pharmacol; 2002 Dec; 54(12):1693-6. PubMed ID: 12542901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of cefazolin in serum or urine.
    Kaye B; Wood PR
    J Pharm Sci; 1978 Aug; 67(8):1170-1. PubMed ID: 671261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.